Neogen Chemicals Limited (NSE:NEOGEN)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	43,702	40,716	31,558	32,077	43,504	20,086
Market Cap Growth	4.31%	29.02%	-1.62%	-26.27%	116.59%	152.32%
Enterprise Value	49,620	45,762	35,928	34,451	46,175	21,441
Last Close Price	1539.80	1543.35	1194.93	1282.37	1736.02	854.99
PE Ratio	120.86	116.90	88.52	64.19	97.48	64.11
Forward PE	51.95	58.52	40.91	42.03	63.74	49.06
PS Ratio	5.57	5.24	4.57	4.68	8.93	5.97
PB Ratio	5.54	5.16	4.15	6.65	9.90	10.98
P/TBV Ratio	5.54	5.16	4.16	6.67	9.91	11.00
P/OCF Ratio	-	20.78	-	-	3085.40	24.04
PEG Ratio	0.82	1.16	1.17	1.16	1.44	2.23
EV/Sales Ratio	6.33	5.89	5.20	5.02	9.48	6.37
EV/EBITDA Ratio	35.37	33.57	34.10	31.48	54.41	34.23
EV/EBIT Ratio	45.06	42.17	41.21	36.10	61.65	37.31
Debt / Equity Ratio	0.76	0.76	0.54	0.77	0.52	1.21
Debt / EBITDA Ratio	4.26	4.38	3.73	3.32	2.64	3.45
Asset Turnover	-	0.49	0.55	0.74	0.76	0.80
Inventory Turnover	-	1.22	1.15	1.62	1.78	1.62
Quick Ratio	-	0.28	0.69	0.75	1.19	0.58
Current Ratio	-	1.36	1.49	1.60	2.26	1.35
Return on Equity (ROE)	-	4.50%	5.74%	10.84%	14.34%	18.47%
Return on Assets (ROA)	-	4.23%	4.33%	6.44%	7.25%	8.48%
Return on Capital (ROIC)	5.38%	5.31%	5.39%	7.85%	8.73%	10.18%
Return on Capital Employed (ROCE)	-	10.70%	9.30%	14.80%	12.90%	18.30%
Earnings Yield	0.77%	0.85%	1.13%	1.56%	1.03%	1.56%
FCF Yield	-	-2.99%	-10.52%	-4.14%	-3.88%	-2.56%
Dividend Yield	0.06%	0.07%	0.17%	0.23%	0.16%	0.26%
Payout Ratio	-	15.16%	20.98%	13.73%	11.76%	14.91%
Buyback Yield / Dilution	-1.84%	-3.31%	-2.41%	-	-6.88%	0.00%
Total Shareholder Return	-1.78%	-3.25%	-2.24%	0.23%	-6.72%	0.27%

Updated Feb 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.